Market’s First and Only HIV-1 Protease Inhibitor Screening Kit (Fluorometric)

MILPITAS, Calif. - June 24, 2015 - PRLog -- HIV-1 inhibitors’ research is at the forefront of active antiretroviral and cancer therapeutics. BioVision is proud to introduce the industry’s first HIV Protease Inhibitor Screening Kit (Cat # K826-100), which can be used to screen/study/characterize potential HIV inhibitors in a lab setting.

Salient features of this kit:
- Simple, plate based fluorometric assay
- No other additional equipment required
- High throughput adaptable

We also offer the Active HIV1 protease recombinant protein (Cat # 7849) for your supplementary research use. This ≥ 90% pure active protein is made in E.Coli and can be used for various applications, such as:
- Activity assays, Inhibitor assays, selectivity profiling, western blotting, ELISA, etc.

Find more information for the HIV-1 Protease Inhibitor Screening Kit here:

http://www.biovision.com/hiv-1-protease-inhibitor-screening-kit-fluorometric-10055.html

Find more information about the active HIV1 Protease recombinant protein here:

http://www.biovision.com/active-hiv1-protease-recombinant-gst-tagged-9987.html

In addition, take advantage of our 15% off promo on any size of Proteins, Biochemicals & Antibodies between 07/01 and 08/31. US customers only. Cannot be combined with any other offers.